Skip to main content

Peer Review reports

From: Down-regulated HHLA2 enhances neoadjuvant immunotherapy efficacy in patients with non-small cell lung cancer (NSCLC) with chronic obstructive pulmonary disease (COPD)

Original Submission
24 Jan 2024 Submitted Original manuscript
15 Feb 2024 Reviewed Reviewer Report
17 Feb 2024 Reviewed Reviewer Report
2 Mar 2024 Author responded Author comments - Jie Dai
Resubmission - Version 2
2 Mar 2024 Submitted Manuscript version 2
Publishing
17 Mar 2024 Editorially accepted
29 Mar 2024 Article published 10.1186/s12885-024-12137-5

You can find further information about peer review here.

Back to article page